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A B S T R A C T   
Skin is the largest organ of the body with important protective functions, which become compromised with time 
due to both intrinsic and extrinsic ageing processes. Cellular senescence is the primary ageing process at cell 
level, associated with loss of proliferative capacity, mitochondrial dysfunction and significantly altered patterns 
of expression and secretion of bioactive molecules. Intervention experiments have proven cell senescence as a 
relevant cause of ageing in many organs. In case of skin, accumulation of senescence in all major compartments 
with ageing is well documented and might be responsible for most, if not all, the molecular changes observed 
during ageing. Incorporation of senescent cells into in-vitro skin models (specifically 3D full thickness models) 
recapitulates changes typically associated with skin ageing. However, crucial evidence is still missing. A bene-
ficial effect of senescent cell ablation on skin ageing has so far only been shown following rather unspecific 
interventions or in transgenic mouse models. We conclude that evidence for cellular senescence as a relevant 
cause of intrinsic skin ageing is highly suggestive but not yet completely conclusive.   
1. Ageing of the skin 
Skin is a complex organ that comprises several compartments with 
different functions. It is the largest organ covering the human body, with 
a surface area of approximately 1.5–2 m2, and has direct contact with 
the external environment. The skin consists of three layers, namely the 
epidermis, dermis, and hypodermis (Fig. 1). The epidermis is the 
outermost layer that has a protective function to prevent penetration of 
pathogens and regulate water loss from the body. The dermis contains a 
dense extracellular matrix network that provides the skin with me-
chanical strength and elastic recoil, and the subcutaneous fat within the 
hypodermis provides insulation. 
The epidermis has a stratified, squamous organization with a 
multitude of cell types including mechanosensory Merkel cells, antigen- 
presenting Langerhans cells, pigmented melanocytes, and keratinocytes, 
which are the most abundant cell type (Brenner and Hearing, 2008). 
Epidermal stem cells within the stratum basale give rise to progenitor 
cells, which undergo programmed, sequential differentiation to form the 
suprabasal stratum spinosum, stratum granulosum and terminally differ-
entiated stratum corneum. 
The dermis has a complex architecture, maintained by dynamic 
reciprocity between the dermal-resident cells and a composite network 
of extracellular matrix. The dermis contains two morphologically 
distinct layers known as the papillary and reticular dermis, which differ 
in structure and composition. The papillary dermis contains fine and 
sparsely arranged collagen, oxytalan and elaunin fibers, with a 
perpendicular orientation to the dermal-epidermal junction. The retic-
ular dermis contains a dense network of collagen and elastic fibers, 
embedded within a non-fibrous ground substance of glycoproteins, 
proteoglycans and glycosaminoglycans. Fibroblasts in the papillary and 
reticular compartments differ by morphology, growth potential, secre-
tion of cytokines and matrix-modifying enzymes (Mine et al., 2009), 
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lineage marker expression and differentiation potential (Korosec et al., 
2019) and their ability to support keratinocyte differentiation (Janson 
et al., 2017; Lämmermann et al., 2018; Mine et al., 2009). 
The hypodermis resides beneath the dermis, and it connects the skin 
to the underlying fascia. The hypodermal adipose tissue is composed of 
lobules of adipocytes separated by connective tissue septae, which 
provide the skin with insulation and storage (Khavkin and Ellis, 2011). 
The principal function of skin is to act as a barrier, which protects 
against potential exterior insults such as pathogens, chemicals and 
physical stressors and helps to maintain the body’s interior homeostatic 
balance. The responsibility for providing the physical barrier function 
rests mainly on the keratinocytes of the epidermis, with the stratum 
corneum contributing significantly to barrier properties (Choi, 2019). 
The skin is not entirely impermeable; water loss to the external envi-
ronment, also known as transepidermal water loss (TEWL), contributes 
to water loss from the body, and is also used as one of a range of methods 
to functionally assess the skin’s barrier function. Other surrogate 
markers that are accepted as indicative of barrier function include 
stratum corneum hydration, sebum levels and pH (Luebberding et al., 
2013). More indirect techniques, e.g., tape stripping may also be used to 
analyze the lipid composition of the stratum corneum, either through 
mass spectroscopy of samples or via techniques such as corneosurfa-
metry, where the lipid composition of tape stripped, samples is analyzed 
using histological stains and colorimetry. These techniques can be 
adapted to measure the impact of interventions on (aged) skin and in 3D 
organotypic models (Alexander et al., 2018; Srinivasan et al., 2015). 
Skin ageing is a process associated with both intrinsic and extrinsic 
factors that leads to a progressive loss of structural integrity and phys-
iological function (Friedman, 2005), ( Fig. 2). 
Fig. 1. Human skin structure. The epidermal 
layer is separated from the underlying dermis 
by a basement membrane. The epidermis is 
mainly composed of keratinocytes. During cell 
differentiation, cells become flatter with thick-
ening of cell membranes as they are pushed 
towards the stratum corneum. The stages of dif-
ferentiation are characterized by expression of 
specific keratins as listed above. In the stratum 
granulosum, smaller dark purple dots in the cells 
represent lamellar granulosum that serve as 
water barrier. Melanocytes locate within the 
stratum basale of the epidermis. They provide 
skin color and protect skin from UV damage. 
The dermis is a fibrous layer rich in collagen and elastin that are produced by fibroblasts. Hypodermis is the deepest layer of the skin that is made up of loose 
connective tissues and fat. For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.   
Fig. 2. Skin ageing is driven by both intrinsic 
(e.g., ROS, skin repair impairment, hormones) 
and extrinsic (e.g., smoking, UV exposure, 
environmental pollution) factors. Ageing phe-
notypes caused by intrinsic factors are partially 
different from those driven by extrinsic ageing. 
Characteristic signs of intrinsic ageing include 
epidermal thinning, fine wrinkles, loss of elas-
ticity, aberrant pigmentation, hair graying and 
smooth appearance. Factors such as UV expo-
sure, cigarette smoke and environmental pol-
lutants drive extrinsic skin ageing. Extrinsically 
aged skin appears thick and rough, with coarse 
wrinkles, skin laxity, pigmentation changes and 
visible appearance of blood vessels under the 
skin surface (telangiectasia).   
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Extrinsic skin ageing is defined as the cumulative effects of lifestyle 
and environmental factors including ultraviolet radiation (UV), smoking 
and environmental pollution. More comprehensively, (Krutmann et al., 
2017) introduced the concept of the skin ageing exposome and defined 
the environmental factors which are part of it as belonging to the 
following major categories: (i) sun radiations: ultraviolet radiation, 
visible light and infrared radiation, (ii) air pollution, (iii) tobacco smoke, 
(iv) nutrition, (v) a number of less well studied, miscellaneous factors, as 
well as (vi) cosmetic products. 
Phenotypically, extrinsic skin ageing is characterized by deep wrin-
kles, skin laxity, roughness, pigmentation changes and visible appear-
ance of blood vessels under the skin surface, known as telangiectasia 
(Wlaschek et al., 2001). Unlike intrinsically aged skin, extrinsic skin 
ageing (UV-irradiated) demonstrates a thickened epidermis, especially 
in the stratum corneum (Kligman, 1989) due to corneocyte desmosomes 
failing to degrade effectively. Following UV irradiation, involucrin was 
increased in the stratum corneum, whilst β1-integrin was greatly reduced 
in basal cells, indicating that UV causes the impairment of keratinocyte 
differentiation (Makrantonaki and Zouboulis, 2007). In young skin, 
elastin and collagen fibers are tightly packed and highly organized, but 
in extrinsic skin ageing the organization of collagen bundles is altered 
(Quan and Fisher, 2015; Yasui et al., 2013) associated with collagen 
deficiency. Specifically, collagen I is greatly diminished resulting in an 
increased ratio of type III to type I collagen. The loss of functional me-
lanocytes and alterations in the interactions between melanocytes and 
keratinocytes leads to protective barrier dysfunction against UV radia-
tion (Brenner and Hearing, 2008). Furthermore, in response to extrinsic 
ageing factors such as exposure to UV radiation, alterations in TEWL 
have been observed as an acute stress response (Choi, 2019). 
The induction of photoaging together with multiple markers of cell 
senescence by UVB in vivo has been demonstrated using p16INK4A re-
porter mice (Sorrentino et al., 2014) and there is extensive literature on 
the induction of senescence and skin aging by multiple components of 
the skin exposome including the UV modalities UVA and UVB (Krut-
mann et al., 2021). 
Intrinsic skin ageing is described as a natural consequence of phys-
iological changes over time such as the generation of reactive oxygen 
species (ROS), hormonal shifts, impairment to repair skin damage 
(Farage et al., 2008) and, possibly, cell senescence. It is characterized by 
visible signs of epidermis thinning, fine wrinkles, loss of elasticity, 
aberrant pigmentation, smoothness, and hair graying. Skin thinning is 
the most remarkable change in intrinsic skin ageing (Waller and Mai-
bach, 2005). The epidermis retains its multi-layered, keratinized struc-
ture with age, however, decreased epidermal thickness, reduced 
epidermal turnover and strata-specific alterations have been well 
documented (Table 1). Dermal ageing is associated with chronic atro-
phy, attributed to the degradation of the extracellular matrix networks, 
which causes reduced elasticity, decreased extensibility and increased 
laxity of the skin (Table 1). The distance between dermo-epidermal 
junction decreases and leads to insufficient nutrition supply to the 
epidermis ultimately reducing basal cell proliferation. In sun-protected 
areas, the aged dermis contains fewer mast cells, fewer fibroblasts 
(especially papillary fibroblasts) and less collagen, as well as elastic fi-
bers as compared to sun-protected young dermis (Kohl et al., 2011). It 
was stated that the thinning of superficial dermis is due to gradual lysis 
of connective tissues, while the increase in density is caused by the 
thinnest fibers being degraded first, leaving thicker collagen fibers in the 
deep dermis. This may also explain why the resistance of the skin 
weakens at the surface (Bonta et al., 2013). The loss of collagen content 
is associated with upregulation of collagen degrading enzymes, i.e., 
matrix metalloproteinases (MMPs) (Rittié and Fisher, 2002) along with a 
decrease in collagen synthesis. The age-related loss of subcutaneous fat 
from the hypodermis contributes to the wrinkling and sagging of ageing 
skin (Ezure and Amano, 2010). 
Epidermal thinning and flattening of the dermo-epidermal junction 
can result in increased skin fragility and reduced resistance to shearing 
forces. These lead to increased potential for barrier disruption and 
delayed barrier repair, although stratum corneum thickness and TEWL 
may be maintained during chronological ageing (Rittié and Fisher, 
2015). Changes in skin pH occur during aging, impacting on the activity 
of enzymes involved in stratum corneum barrier formation (Schmid--
Wendtner and Korting, 2006; Wang et al., 2020). 
A range of diverse molecular mechanisms has been shown to be 
associated with skin ageing. Some of the major mechanisms are: 
Oxidative stress is thought to be an important contributing factor in 
both intrinsic and, to an even larger extent, extrinsic skin ageing and 
dermal damage (Kammeyer and Luiten, 2015; Rittié and Fisher, 2002). 
Reactive oxygen species (ROS) are mainly generated by mitochondria 
and can be protective against skin infection by activating 
hypoxia-inducible factor 1-alpha (HIF1α) and recruiting immune cells 
(Hamanaka and Chandel, 2009). However, the accumulation of exces-
sive ROS can cause damage to macromolecules (lipids, DNA and pro-
teins) leading to cellular dysfunction. For instance, accumulation of 
cellular lipofuscin, containing oxidized lipids and cross-linked proteins, 
has been detected in fibroblasts and keratinocytes during ageing (Katz 
and Robison, 2002). Generation of macromolecular damage interferes 
both directly and indirectly with the major proteostatic systems of the 
cell, the Ubiquitin-proteasome system and the autophagosome/ly-
sosome system (Korovila et al., 2017). Elevated ROS production acti-
vates the mitogen-activated protein kinase (MAPK) pathway, which 
consequently stimulates the production of activator protein 1 (AP-1). 
AP-1 transcriptionally regulates matrix metalloproteinases (MMPs) 
which determine composition and amount of the extracellular matrix 
(ECM) in the dermis. MMP-1 cleaves collagen, which is further degraded 
by MMP-3 and MMP-9. On the other hand, tissue inhibitors of metal-
loproteinases (TIMPs) are downregulated during the ageing process 
(Fisher and Voorhees, 1998). UV radiation can also stimulate MMP 
expression, perhaps through the DNA damage response (DDR) pathway 
leading to the activation of MAPK and transforming growth factor-beta 1 
(TGF-β1). Among other effects, TGF-β1 regulates the production and 
degradation of collagen in the ECM, thus affecting the structure and 
integrity of dermal fibroblasts (Quan et al., 2010). 
Mitochondrial DNA (mtDNA) and nuclear DNA damage and 
epigenetic changes. DNA damage can occur by endogenous mitochon-
drial ROS production. Mitochondrial DNA mutations, including de-
letions and point mutations of mtDNA, accumulate in skin during ageing 
and following UV irradiation. mtDNA damage can exacerbate mito-
chondrial ROS production, it can also induce premature aging in model 
systems (Kujoth et al., 2005; Trifunovic et al., 2004) including wrinkle 
formation and hair loss (Singh et al., 2018). 
Shifts in histone chromatin marks, including markedly reduced 
levels of H4K16ac, absence of high H4K20me1 staining and increased 
cell-to-cell variability in total histone H3 and H4 content, are charac-
teristic for ageing in the basal keratinocytes (Dube et al., 2021) together 
with decreased expression of multiple histone deacetylases (Lee et al., 
2021a). DNA methylation changes characteristically with age in human 
keratinocytes and fibroblasts, providing a basis for a skin cell-based 
methylation clock and, possibly, for the validation of anti-ageing in-
terventions in skin (Boroni et al., 2020; Horvath et al., 2018). 
Skin ageing may also be driven by damage to nuclear DNA, especially 
to telomeres (Aguado et al., 2019; Victorelli and Passos, 2020). Telo-
meres not only shorten gradually with age due to the end replication 
problem but also accumulate damage that causes premature shortening 
(von Zglinicki, 2002) and/or induction of a persistent DNA damage 
response at telomeres (Herbig et al., 2006; Hewitt et al., 2012) which is 
an efficient trigger of cell senescence. In mice, telomere shortening 
impaired the function of epidermal stem cells (Flores et al., 2005). In 
humans, basal cells in UV exposed skin regions have been found to have 
shorter telomeres in comparison to sun-protected regions (Ikeda et al., 
2014), which may be explained by the fact that UV radiation specifically 
targets telomeric GGG triplets (Oikawa et al., 2001). In sun-protected 
human epidermis, little or no telomere loss with ageing was found 
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(Krunic et al., 2009; Victorelli et al., 2019). This might be due to the fact 
that keratinocytes - at least in the basal stem cells - express active 
telomerase (Härle-Bachor and Boukamp, 1996; Krunic et al., 2009). 
However, the number of skin cells displaying a telomeric DDR inde-
pendently of telomere length (indicated by telomere-associated DNA 
damage foci, TAF) increased significantly with age in the skin of ba-
boons (Herbig et al., 2006) and in melanocytes and keratinocytes in situ 
in human skin (Victorelli et al., 2019). 
Cytokine production is altered during skin ageing leading to im-
balances of various proinflammatory components such as interleukins 
and tumor necrosis factor alpha (TNF-α) that stimulate upregulation of 
metalloproteinases including MMP-9. Interleukins (IL)-1 and IL-18 
accumulate with age and contribute to skin inflammation and IL-1, IL- 
6, IL-8, IL-10, IL-15, and TNF- α increase after UV exposure in kerati-
nocytes (Strickland et al., 1997) and dermal fibroblasts (de Kossodo 
et al., 1995). Fibroblasts from intrinsically aged skin increase production 
of cysteine-rich protein 61 (CCN1), which causes alteration of collagen 
homeostasis leading to skin dysfunction (Waldera Lupa et al., 2015). 
As this incomplete overview of molecular mechanisms shows, skin 
aging is a multi-causal process with loss of tissue and cell homeostasis, 
loss of proteostasis, increased protein oxidation, reduced immune ca-
pacities for senescence clearance, impaired DNA repair competence and 
others. Thus, it can be doubted whether cellular senescence is decisive 
for all this changes. It is, however, intriguing that most, if not all, of the 
above indicated molecular mechanisms associated with skin ageing are 
similarly known in cellular senescence. For instance, cell senescence is 
typically driven by telomere dysfunction and ensuing DNA damage 
response (d’Adda di Fagagna et al., 2003), stabilized by mitochondrial 
dysfunction and production of high levels of ROS (Correia-Melo et al., 
2016; Passos et al., 2010) as well as by cytokine (SASP) release (Acosta 
et al., 2008; Campisi et al., 2019; Coppé et al., 2010) and accompanied 
by major epigenetic reprogramming (Shah et al., 2013) and 
autophagy/mitophagy dysfunction (Korolchuk et al., 2017) (for review, 
see Gorgoulis et al., 2019; von Zglinicki, 2021). This raises the possi-
bility that cell senescence might be an underlying core mechanism of 
skin ageing. 
In fact, cell senescence, especially senescence of dermal fibroblasts, 
has been postulated as a driver of skin ageing in many recent reviews 
(Campisi et al., 2019; Demaria et al., 2015; Fitsiou et al., 2021; Ho and 
Dreesen, 2021; Lee et al., 2021b; Toutfaire et al., 2017; Velarde and 
Demaria, 2016; Wang and Dreesen, 2018; Wlaschek et al., 2021). There 
is already good evidence for a causal role of cell senescence in photo-
aging of the skin, which has been covered in multiple recent reviews 
(Cavinato and Jansen-Dürr, 2017; Fitsiou et al., 2021; Toutfaire et al., 
2017; Velarde and Demaria, 2016). However, a driving role of cell 
senescence in intrinsic ageing of photo-protected skin is less well evi-
denced, and this will the primary focus of the reminder of this review. 
2. Cellular senescence 
2.1. What is cellular senescence? 
Replicative senescence was first established in 1961 by Hayflick and 
Moorhead as the irreversible loss of proliferative capacity after a 
reproducible number of population doublings in culture (Hayflick and 
Moorhead, 1961). Later, replicative senescence was linked to telomere 
attrition as telomeres in somatic human cells shorten with each cell 
division (Harley et al., 1990). It was demonstrated that telomerase could 
protect telomeres from shortening, thus preventing replicative senes-
cence (Bodnar et al., 1998). Progressive telomere loss results in chro-
mosome ends recognized as double strand breaks (DSB), which provokes 
the activation of a DNA damage response (DDR) that, if it persists, causes 
senescence (d’Adda di Fagagna et al., 2003). Telomeres are not very 
accessible to the DNA repair machinery (Doksani and de Lange, 2014; 
Table 1 
Structural changes of human skin during intrinsic ageing of sun-protected skin.  
Layer Sublayers Age-related changes Expected physiological and pathological consequences 
Epidermis General Decreased epidermal thickness May lead to changes in barrier function, such as increased water loss 
and susceptibility to infections (Rorteau et al., 2020) 
Stratum 
corneum 
Altered lipid composition Changes in barrier function and skin dryness (Starr et al., 2016) 
Stratum 
granulosum 
No significant difference in keratinocyte size, nuclear size or nuclear: 




Apoptosis of keratinocytes (Gilhar et al., 2004) May reflect reduced proliferative capacity, leading to reduced 
epidermal thickness (Rübe et al., 2021) 
Stratum 
basale 
Reduced proliferative capacity of basal keratinocytes (Rübe et al., 
2021) 
Reduced height of basal keratinocytes (Sauermann et al., 2002) 
Increased size of basal keratinocytes and nuclei (Liao et al., 2013) 
Decreased number of melanocytes (Gilchrest et al., 1979) 
Changes in the balance between differentiation and proliferation of 
basal keratinocytes, resulting in reduced maintenance of stratified 
layers (Charruyer et al., 2021; Rorteau et al., 2020) and an overall 
reduction in epidermal thickness (Gilhar et al., 2004). Irregular skin 
pigmentation, both hyperpigmentation and hypopigmentation (Y. Lee, 




– Reduced height of dermal papilla (Sauermann et al., 2002) 
Reduced height of rete ridges and flattening of dermo-epidermal 
junction (Newton et al., 2017) 
May lead to changes in skin barrier function (increased water loss and 
infection susceptibility) (Rorteau et al., 2020), as well as reduced 
resistance to shearing (Langton et al., 2019) 
Dermis Papillary Decreased quantity and thickness of collagen bundles (Marcos-Garcés 
et al., 2014) 
Altered orientation of collagen fibers in the reticular dermis ( 
Marcos-Garcés et al., 2014) 
Decreased numbers of fibroblasts with papillary morphology (Mine 
et al., 2009) 
Impact on biomechanics of skin, specifically elasticity and stiffness ( 
Langton et al., 2019) which may lead to increased instability and 
wrinkling (Kruglikov and Scherer, 2018) 
Reticular Collapsed morphology of fibroblasts (Fisher et al., 2008) 
Altered composition of fibroblast secretome with an upregulation of 
proinflammatory cytokines, pro-oxidant components and matrix 
degrading factors (Waldera Lupa et al., 2015) 
Chronic degradation of the collagen and elastin networks by matrix 
metalloproteinases (Ashworth et al., 1999) 
Reduction in tissue inhibitor of metalloproteinases (TIMPs) 
Decreased quantity of interstitial collagen (Varani et al., 2006) 
40% reduction in the ground substance (Li et al., 2013) 
Imbalance between ECM synthesis and degradation, leading to changes 
in architecture and loss of dermal volume (Rorteau et al., 2020) 
Impact on skin biomechanics - loss of skin elasticity and increased 
dermal stiffness (Langton et al., 2019; Strnadova et al., 2019) 
Increased risk of lacerations, delayed wound healing and increased risk 
of infections and bleeding (Strnadova et al., 2019; Wollina et al., 2019) 
Hypodermis – Relative loss of subcutaneous fat (Ezure and Amano, 2010) Reduced protection from infection and trauma and potential metabolic 
disturbances (Tchkonia et al., 2010)  
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Richter et al., 2007), resulting in persistent DNA damage foci that are 
potent inducers of senescence or apoptosis (Fumagalli et al., 2012; 
Hewitt et al., 2012). 
In vivo, replicative exhaustion is just one inducer of senescence and 
other stresses, including DNA-damaging ROS, radiation or oncogene 
expression can be much more prominent. While telomere uncapping 
remains a general characteristic of senescent cells in the vast majority of 
stress response modes, a wide variety can be observed in senescent 
phenotypes and differences in the inducer mechanism is one determi-
nant of this variety (Tigges et al., 2014; Waldera Lupa et al., 2015). 
Multiple biomarkers are in use to detect the presence of senescent 
cells in vivo: A long-established marker is the expression of lysosomal 
β-galactosidase activity at sub-optimal pH (Senescence-Associated 
β-Galactosidase, SA-β-Gal), which increased with age in human skin 
(Dimri et al., 1995). Many biomarkers of senescence are based on the 
upregulation of cell cycle inhibitors including p16INK4a, p21WAF1/-
CIP1, p53, ARF, p15 and p27 and downregulation of 
proliferation-associated proteins (Beauséjour et al., 2003). Additional 
markers are loss of LaminB1, a structural component of the nuclear 
lamina (Dreesen et al., 2013; Wang et al., 2017) or translocation of high 
mobility group box-1 (HMGB1) from nuclei (Biran et al., 2017). The 
colocalization of DNA damage foci (typically assessed by γH2AX im-
munostaining) and telomeres by ImmunoFISH (telomere-associated 
foci, TAF) (Herbig et al., 2006; Hewitt et al., 2012) is a powerful indi-
cator for a persistent DDR driving senescence. Importantly, sensitivi-
ty/specificity of any one of these senescence biomarkers is insufficient 
for a decisive identification of a senescent cell. This has multiple causes: 
i) most of the markers named above (with the possible exception of TAF) 
are also expressed by cells in stress situations that not necessarily lead to 
senescence; ii) senescence is a complex phenotype that can vary signif-
icantly depending on cell type, senescence inducer and kinetic factors 
such that not every senescent cell will express all the markers listed, and 
iii) methodological issues with marker sensitivity that so far, despite 
some interesting progress (Biran et al., 2017), exclude a fully quantita-
tive assessment of senescent cell frequencies in any tissue. Accordingly, 
the combined use of multiple biomarkers is now a standard requirement 
for the identification of changes in senescence abundance (Gorgoulis 
et al., 2019; von Zglinicki, 2021). 
Although senescent cells are unable to divide, they remain meta-
bolically active (de Magalhães and Passos, 2018), which allows them to 
develop a plethora of phenotypic changes or ‘building blocks’ (von 
Zglinicki, 2021). These building blocks interact closely with each other, 
leading to the long-term stability of the senescence stress response. For 
instance, Senescence-Associated Mitochondrial Dysfunction results in 
enhanced ROS production that stabilizes senescence by maintaining a 
persistent DDR (Passos et al., 2010). In fact, mitochondria are essential 
for establishment of cell senescence (Correia-Melo et al., 2016). 
A very important ‘building block’ is the so-called Senescence-Asso-
ciated Secretory Phenotype (SASP). Senescent cells release a large 
number of biologically active molecules, including pro-inflammatory 
cytokines and chemokines, growth factors and matrix metal-
loproteinases (Coppé et al., 2008) but also non-peptide factors including 
vesicles encapsulating miRNAs, oxidized lipids, reactive oxygen species 
and others (Nelson et al., 2012; Weilner et al., 2013). The composition of 
the SASP varies widely with cell type, senescence inducer, kinetic pro-
gression through the senescent phenotype and, probably, a host of 
additional factors (Kirschner et al., 2020). For instance, fibroblasts that 
enter senescence initially predominantly secrete anti-inflammatory 
chemokines and TGF-β in a pathway driven by Notch-1 (Hoare and 
Narita, 2017), while later ROS- and p38MAPK-induced activation of 
NF-kB and C/EBPbeta results in a pro-inflammatory SASP (Acosta et al., 
2008; Coppé et al., 2008). Recently, COX-2 emerged as another critical 
regulator of SASP composition (Gonçalves et al., 2021). The SASP at-
tracts phagocytic immune cells and thus contributes to senescence res-
olution. However, it also stabilizes senescence in an autocrine fashion 
(Acosta et al., 2008; Kuilman et al., 2008) and can even induce it in 
neighboring somatic cells (Acosta et al., 2013; Nelson et al., 2012), thus 
amplifying senescence within tissues (da Silva et al., 2019) and 
system-wide (Xu et al., 2018a). SASP components including TGF-β 
modulate differentiation and proliferation capabilities of stem and 
progenitor cells (Xu et al., 2018b). SASP interleukins and chemokines 
contribute to tissue and systemic chronic inflammation (Franceschi 
et al., 2000; Lee et al., 2021b) and MMPs secreted as part of the SASP 
may cause matrix remodeling and degeneration (Varela-Eirín et al., 
2018). 
Accordingly, a recent definition describes senescence as a stress 
response comprising proliferation arrest together with a range of 
phenotypic building blocks (SASP, mitochondrial dysfunction, epige-
netic reprogramming, etc.) in close interaction (Gorgoulis et al., 2019; 
von Zglinicki, 2021). This implies that even post-mitotic cells can un-
dergo the same type of stress response. In fact, neurons, myofibers and 
other postmitotic cells have been found to accumulate senescence-like 
changes with age (von Zglinicki et al., 2020). 
2.2. Cell senescence and ageing in vivo 
Senescent cells accumulate in many, if not all, organs, and tissues 
during ageing (Wang et al., 2009) as well as in a wide range of degen-
erative pathologies including, for instance, atherosclerosis (Erusalimsky 
and Kurz, 2005), osteoarthritis (Martin and Buckwalter, 2003), chronic 
lung disease (Noureddine et al., 2011), and precancerous lesions (Col-
lado et al., 2007). The accumulation of senescent hepatocytes and in-
testinal enterocytes has been found to be a predictor of the physiological 
age of mice in different ageing models (Jurk et al., 2014). However, 
evidence for a causal role of senescent cells in ageing, age-related dis-
eases and tumorigenesis came from recent intervention studies that 
specifically ablated senescent cells in mice (termed ‘senolytics’). In 
pharmacogenetic approaches, senescent cells were targeted via the 
p16INK4a promoter, which was used to drive a suicide gene following 
pharmacological induction (Baker et al., 2016, 2011; Demaria et al., 
2014). Furthermore, pharmacologic agents that more or less specifically 
target cell death pathways in senescent cells were also discovered 
(Fuhrmann-Stroissnigg et al., 2017; Zhu et al., 2017, 2016, 2015), 
providing tools that can be translated into the clinic. Intervention ex-
periments with such senolytic approaches in mice postponed 
age-associated functional losses and degradative diseases in a wide 
range of organ systems, including muscle, liver, lung, bone, the car-
diovascular system, and the brain (for review see Robbins et al., 2021). 
Importantly, senolytic interventions also enhanced median lifespan in 
mice (Baker et al., 2016; Yousefzadeh et al., 2018). Moreover, trans-
plantation of low numbers of senescent cells into the visceral fat of mice 
impaired physical function and shortened lifespan of old animals in a 
dose-dependent manner, and these effects were rescued by senolytic 
intervention (Xu et al., 2018a). 
Based on the promising results of pre-clinical experiments in mice, 
over one dozen FDA-approved clinical trials with the senolytics Dasa-
tinib and Quercetin (D+Q), Fisetin, and UBX0101 have been instigated 
to test the systemic treatment of multiple age-related conditions and 
diseases in humans. To date, three trials have reported results. Results of 
the trial using UBX0101 to treat osteoarthritis have been disappointing 
to date (https://clinicaltrials.gov/ct2/show/NCT04229225). However, 
early studies with D+Q appeared more promising. D+Q was used in an 
open-label phase I pilot study to treat subjects with diabetic kidney 
disease (https://clinicaltrials.gov/ct2/show/NCT02848131). Results so 
far strongly suggested that D+Q decreased the burden of senescent cells 
in humans (Hickson et al., 2019). This trial is continuing to ascertain 
whether senolytics alleviate diabetes and its complications. An 
open-label, two-center study of intermittent D+Q treatment in patients 
with idiopathic pulmonary fibrosis (https://clinicaltrials.gov/ct2/-
show/NCT02874989) also was conducted and showed improvements in 
physical function parameters such as gait speed and chair stand time in 
the treated group (Justice et al., 2019). Clinical trials testing Fisetin for 
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chronic kidney disease (https://clinicaltrials.gov/ct2/show/NCT03325 
322), skeletal health (https://clinicaltrials.gov/ct2/show/NCT04313 
634), frailty (https://clinicaltrials.gov/ct2/show/NCT03675724), and 
osteoarthritis (https://clinicaltrials.gov/ct2/show/NCT04210986) are 
under way; no results have been reported yet. Finally, two trials testing 
Fisetin for the prevention of disease progression and death in the elderly 
infected with SARS-CoV-2 (severe acute respiratory syndro-
me–coronavirus 2) were recently registered with the National Institutes 
of Health (https://clinicaltrials.gov/ct2/show/NCT04476953 and 
https://clinicaltrials.gov/ct2/show/NCT04537299). Taken together, 
these results strongly suggest that cell senescence is a significant 
contributor to ageing in many organs and that senolytic agents hold 
promise for treating major age-related diseases. 
However, is this also the case for ageing of the skin? 
3. Evidence for a role of cell senescence in intrinsic skin ageing 
3.1. Correlative data: senescent cells accumulate during skin ageing 
There is good evidence that senescent cells accumulate in essentially 
all compartments of the skin during ageing, not only in sun-exposed skin 
(Cavinato and Jansen-Dürr, 2017; Fitsiou et al., 2021) but also during 
intrinsic ageing of sun-protected skin (see Fig. 3 and Table 2). A recent 
systematic review finds a significant association between senescent cell 
abundance in skin and donor age (Tuttle et al., 2020). However, the 
present knowledge about senescence accumulation during ageing in 
important cell types in the skin is incomplete and, for some cell types, 
non-existent (Table 2). 
3.1.1. Epidermal keratinocytes 
The epidermis is made up of a highly proliferative stratified squa-
mous epithelium (Fig. 1). Stem cells in the basal keratinocyte layer ex-
press telomerase (Härle-Bachor and Boukamp, 1996; Krunic et al., 2009) 
and can thus retain their telomere length, at least during ageing of 
UV-protected skin (Krunic et al., 2009; Victorelli et al., 2019). Stem cells 
produce transient amplifying progenitor cells that detach from the 
basement membrane (Rangel-Huerta and Maldonado, 2017). Their 
progeny migrates towards the epithelial surface and terminally differ-
entiates towards corneocytes, the whole process taking place over 3–6 
weeks. Therefore, the epidermis can eliminate extrinsic macromolecular 
damage through the desquamation of terminally differentiated kerati-
nocytes, thus precluding damage accumulation and rendering the tissue 
compartment comparatively stress resistant. Under high levels of 
oxidative stress, e.g., induced by UVB, keratinocytes, in contrast to fi-
broblasts, can undergo apoptosis as a DNA damage response (Van 
Laethem et al., 2005). These findings led to the view that keratinocytes 
might show very little senescence accumulation during ageing (Ho and 
Dreesen, 2021). However, in the intestine, an epithelium with even 
faster turnover, frequencies of senescent cells specifically in the pro-
genitor compartment increase significantly during ageing, and this was 
driven by telomere uncapping without shortening (Hewitt et al., 2012; 
Jurk et al., 2014; Wang et al., 2009). Similarly, in human epidermis, 
specifically the stratum basale and spinosum/granulosum, cells bearing 
senescence markers including Sen-β-Gal (Dimri et al., 1995; Velarde 
et al., 2012), p16INK4A (Ressler et al., 2006; Rübe et al., 2021; Waaijer 
et al., 2016, 2012), p21WAF1/CIP1 (Victorelli et al., 2019), TAF (Vic-
torelli et al., 2019), H2A.J (Rübe et al., 2021), loss of Lamin B1 (Dreesen 
et al., 2013; Wang et al., 2017) and of HMGB1 (Victorelli et al., 2019) 
have been observed to accumulate with (biological) age. Unfortunately, 
only few studies did clearly discriminate between keratinocytes and 
melanocytes as the next frequent cell type in the epidermis. When this 
was done, it was found that in the epidermis from old donors, almost all 
cells expressing high levels of p16INK4A were melanocytes (Victorelli 
et al., 2019; Waaijer et al., 2016). This result has been interpreted to 
suggest that i) melanocytes present the main population of senescent 
cells in the epidermis, and ii) that p16INK4A might not qualify as a 
marker of senescence in keratinocytes. We will discuss notion i) further 
below (chapter 3.1.2) but would like to caution against notion ii) here 
because high p16INK4A has been shown consistently in primary human 
keratinocytes in replicative, oncogene- und stress-induced senescence 
(Kim et al., 2015; Miyake et al., 2019; Sasaki et al., 2014; Tinaburri 
et al., 2018), and in primary mouse keratinocytes in oncogene- and 
stress-induced senescence (Ritschka et al., 2017) and inactivation of 
p16INK4A immortalized primary human keratinocytes (Maurelli et al., 
2006). There are also arguments against the idea that p16INK4A could 
be upregulated in keratinocytes only during in-vitro, but not during 
in-vivo senescence: p16INK4A is enhanced in primary keratinocyte 
cultures from old donors (Tinaburri et al., 2018) and when skin was 
reconstituted from keratinocytes and fibroblasts only, high p16INK4A 
was found in the basal layer when the reconstitution was done with 
keratinocytes from old donors (Adamus et al., 2014). Interestingly, it has 
been suggested that melanocytes compared to keratinocytes present 
much higher levels of p16INK4A because this acts to repress high ROS 
levels that are a by-product of melanin generation irrespective from cell 
cycle regulation (Jenkins and Grossman, 2013; Jenkins et al., 2011). It 
seems a possibility that the p16INK4A levels in senescent keratinocytes 
in situ might well be below the level of melanocyte p16INK4A and thus 
below the detection threshold in comparative immunostaining. 
Fig. 3. Cell senescence and intrinsic skin ageing. Keratinocytes, melanocytes and fibroblasts express multiple markers of cell senescence associated with physio-
logical indicators of skin ageing, including epidermal thinning and reduced keratinocyte differentiation, decrease of papillary fibroblast frequencies, remodeling of 
the dermal extracellular matrix and loss of subcutaneous fat. See text for further discussion. 
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3.1.2. Melanocytes 
Melanocytes are located at the stratum basale of the epidermis. They 
comprise approximately 1–2% of epidermal cells and are thus the second 
most numerous epidermal cell type after keratinocytes. They produce 
photoprotective melanin pigments, which are transferred to adjacent 
keratinocytes. Differentiated melanocytes have extremely low prolifer-
ative capacity (Taylor et al., 2011), which might suggest that they are 
unlikely to undergo replicative senescence. However, melanocytes have 
long been thought to readily undergo telomere-dependent (but appar-
ently not p21WAF1/CIP1-dependent) senescence (Bandyopadhyay and 
Medrano, 2000), and this has been recognized as an important mecha-
nism to suppress melanoma development (Suram et al., 2012). 
Accordingly, melanocytes expressing senescence markers including high 
p16INK4a were consistently observed in aged human skin and associ-
ated with hyperpigmentation and other morphological markers of bio-
logical age (Victorelli et al., 2019; Waaijer et al., 2016). Moreover, 
evidence for melanocyte-specific telomere dysfunction without signifi-
cant telomere shortening (indicated by TAF) was observed in skin from 
older donors (Victorelli et al., 2019), suggesting that melanocytes are 
susceptible to undergo telomere length-independent stress-induced 
senescence (Victorelli and Passos, 2017). 
The suggestion that melanocytes might constitute the major senes-
cent cell population in the epidermis was based on the almost exclusive 
co-localization of high p16INK4A and melanocyte markers S-100 and 
Melan-A in aged epidermis (Victorelli et al., 2019; Waaijer et al., 2012). 
It was further supported by showing that senescent keratinocytes clus-
tered around senescent melanocytes and that senescent melanocytes can 
induce senescence in neighboring cells via paracrine signaling involving 
IP10, CXCR3 and ROS (Victorelli et al., 2019). However, as discussed 
above, high p16INK4A levels in melanocytes might be partially inde-
pendent of senescence. Moreover, paracrine interactions between se-
nescent and non-senescent skin cells are most probably more complex: 
(Victorelli et al., 2019) showed that senescent melanocytes can induce 
senescence in keratinocytes in 3D epidermal models, but the reverse 
situation, e.g. the induction of melanocyte senescence from senescent 
keratinocytes or fibroblasts has not been formally examined. However, it 
has been shown that senescent fibroblasts can induce skin hyperpig-
mentation, which in turn might drive melanocyte senescence (Yoon 
et al., 2018). Furthermore, stress-induced activation of p53 in kerati-
nocytes drives paracrine induction of melanogenesis (Murase et al., 
2009), see also (Lee et al., 2021b) for review), which is associated with 
enhanced ROS production that might cause melanocyte senescence. At 
the present state of knowledge, it seems to be safe to assume that 
senescence in the epidermis (and possible in the complete skin) can arise 
in any of the main cell types and can be transmitted via paracrine 
bystander signaling to any other cell in the neighborhood. 
3.1.3. Dermal fibroblasts 
Unlike the epidermis, the dermis is unable to remove extrinsic 
damage by cell shedding, and fibroblasts, the main cell type in the 
dermal matrix, proliferate very slowly in vivo (Tigges et al., 2014). The 
loss of protein homeostasis in aged fibroblasts can led to accumulation of 
misfolded and damaged proteins (Tigges et al., 2014), which may cause 
them to senesce (Rodier et al., 2009). Fibroblasts might be more prone to 
accumulation of DNA damage (and thus senescence) than keratinocytes, 
because they are less efficient in global nucleotide excision repair and 
have lower antioxidant capacities (D’Errico et al., 2007). Accordingly, 
the accumulation of fibroblasts bearing multiple senescence markers in 
ageing skin has been documented in mice, baboons and humans (Dimri 
et al., 1995; Herbig et al., 2006; Lewis et al., 2011; Ressler et al., 2006; 
Waaijer et al., 2012; Wang et al., 2009). However, quantitative esti-
mates of senescent cell frequencies varied widely among studies. For 
instance, in mouse dermis, frequencies of γH2AX-positive fibroblasts 
increased from about 1% in adults to 5% in animals aged 42 months 
(Wang et al., 2009). In the dermis of old (>25 years) baboons, about 
20% of the fibroblasts were TAF-positive and up to 80% were positive 
for the heterochromatin marker HIRA (Herbig et al., 2006). In human 
dermis, the numbers of p16-positive cells increased at least two-fold 
between middle and old age (below and above 70 years) (Ressler 
et al., 2006). Using nuclear morphology as a marker of senescence, 
(Lewis et al., 2011) estimated an increase of senescent cells from about 
25 to almost 60% in sun-protected papillary dermis in a cross-sectional 
comparison of young adult and geriatric volunteers. One important 
source of the variation between studies is the use of different senescence 
markers which are often unvalidated or not sensitive. Therefore, it still 
remains unclear how many senescent cells accumulate in aged skin and 
to which extent species or anatomical localization differences might 
have an impact on the rate of senescent cell accumulation. 
An insufficiently examined question relates to the differences in 
ageing between papillary and reticular fibroblasts and the role of cell 
Table 2 
Overview of skin cell senescence.  
localization Cell type Senescence markers Main references 
Epidermis keratinocytes SA-β-Gal 
MMP-1, MMP-3, MMP-9 
LaminB1 
P21WAF1/CIP1, TAF, HMGB1 
p16INK4a 
HMGB1 
(Dimri et al., 1995) 
(Velarde et al., 2012) 
(Quan et al., 2009) 
(Wang et al., 2017) 
(Victorelli et al., 2019) 
(Ressler et al., 2006) 
(Waaijer et al., 2012) 
(Johnson et al., 2013) 
Str basale melanocyte p16INK4a, TAF, HMGB1 
LaminB1 (nevi) 
IL-6 (nevi) 
(Victorelli et al., 2019) 
(Ivanov et al., 2013) 
(Ghosh and Capell, 2016) 
Epidermis Langerhans cells unknown (Lee et al., 2021b) 
Dermis Fibroblasts TAF, p16INK4a 
p16INK4a 
Nuclear morphology 
(Herbig et al., 2006) 
(Ressler et al., 2006) 
(Waaijer et al., 2012) 
Dermal vasculature Endothelial cells In skin: unknown 
Other tissues: p16, p21WAF1/CIP1, Sen-b-Gal, SASP 
(Sun and Feinberg, 2021) 
Dermal vasculature Smooth muscle cells In skin: unknown 
Other tissues: p16, p21WAF1/CIP1, Sen-b-Gal, SASP 
(Chi et al., 2019) 
Dermis macrophages In skin: unknown 
Other tissues: p16, Sen-β-Gal in response to stimulation (non-senescent) 
(Guimarães et al., 2021) 
(De Maeyer and Chambers, 2021) 
(Hall et al., 2017) 
Dermis Dermal dendritic cells Unknown  
Dermis Mast cells Unknown  
Dermis γδ T cells Unknown   
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senescence in it. Fibroblasts in the papillary region of the dermis in 
young donors are smaller, have higher growth rates, secrete fewer cy-
tokines and matrix metalloproteinases and support keratinocyte differ-
entiation better than reticular fibroblasts. However, during ageing 
fibroblasts in the papillary compartment become more similar to retic-
ular ones, while properties of the reticular population remain un-
changed (Janson et al., 2017; Lämmermann et al., 2018; Mine et al., 
2009). These results may be interpreted differently. For instance, 
papillary and reticular fibroblasts might belong to different lineages, 
and papillary fibroblasts might (trans-)differentiate into reticular ones 
during ageing (Korosec et al., 2019; Lämmermann et al., 2018). Another 
possibility could be that reticular fibroblasts from young donors already 
contain a higher fraction of senescent cells, and that papillary fibroblasts 
reach similar senescent fractions only in old skin. This interpretation is 
in accordance with data showing that treatment of reticular fibroblasts 
with a senolytic drug changed their phenotype towards papillary cells, 
while it had no effect on papillary fibroblasts from a young donor. 
Multiple senescence markers need to be analyzed separately on papillary 
and reticular fibroblasts to address this question. 
3.1.4. Other cell types in the skin 
In subcutaneous fat, adipocyte progenitors become senescent with 
increasing donor age (Sepe et al., 2011; Tchkonia et al., 2010). Fre-
quencies of senescent preadipocytes in subcutaneous fat (assessed as 
γH2AX-positive, Ki67-negative cells) increased from about 3% to 10% 
with age in both humans and rats (Xu et al., 2015). Presence of senescent 
fat cells in the subcutaneous layer has been associated with chronic 
inflammation (Palmer et al., 2019), however, whether subcutaneous 
senescent preadipocytes can enhance senescence in other layers of the 
skin has not been examined yet. 
It is well established that skin-resident immune cells respond to the 
chronic low-level inflammation associated with skin ageing (Lee et al., 
2021b). However, to our knowledge, no information is available about 
whether these cells senesce and to what extent this may contribute to 
skin ageing. Similarly, there is essentially no information available 
about senescence in the dermal vasculature (Tab 2). 
3.2. Modifying frequencies of senescent cells in 3D skin equivalents 
Tissue engineered organotypic models are valuable tools to study the 
influence of senescent cells in human skin ageing. Bioengineered skin 
equivalents capture the multicellular and multi-layered complexity of 
human skin in vitro and enable interactions between different cell 
populations to be studied. To study the contribution of senescence to the 
ageing phenotype in vitro, 3D skin-equivalents have been developed 
that incorporate senescent cells (Diekmann et al., 2016; Janson et al., 
2013; Lämmermann et al., 2018; Weinmüllner et al., 2020). A major 
limitation of these models is their simplified composition: frequently 
they consist of matrix-embedded fibroblasts and keratinocytes only. 
While epidermal models composed of keratinocytes and melanocytes 
have been successfully used for ageing studies (Victorelli et al., 2019), 
effects of ageing/senescence in skin 3D equivalents containing resident 
immune cells have not yet been studied to our knowledge. Moreover, the 
interactions of different dermal equivalent matrices with senescent skin 
cells have not been systematically examined. 
In a study which incorporated mitomycin C-induced senescent fi-
broblasts into 3D skin equivalents, age-related changes including an 
increase in matrix-degrading enzymes, the prominent degradation of the 
extracellular matrix networks, and decreased filaggrin expression in the 
upper epidermis were observed (Diekmann et al., 2016). Another study 
developed human skin equivalents using early or late passage fibro-
blasts, to mimic young and aged skin. The incorporation of late passage 
fibroblasts produced a thinner dermis, which may be explained by an 
increase in MMP1 secretion. These models also provided evidence of 
dermal-epidermal crosstalk, as the late passage fibroblasts induced al-
terations in epidermal differentiation such as an increased expression of 
keratin 6 and a decrease in keratin 10 (Janson et al., 2013). A study 
focusing on the impact of epidermal-dermal crosstalk with age found 
that increasing the ratios of either oxidative stress-induced or 
doxorubicin-induced senescent cells within the dermis caused a pro-
gressive thinning of the epidermis. In addition to epidermal thinning, 
the co-culture with senescent fibroblasts also altered epidermal differ-
entiation and barrier function in the model, with a decrease in keratin 10 
and filaggrin, and partial impairment of barrier integrity as measured by 
biotin permeability assay (Weinmüllner et al., 2020). Conversely, 
treatment of full thickness 3D skin models with an alcoholic extract of 
Solidago alpestris, which had weak senolytic activity in vitro and sup-
pressed the SASP, enhanced the papillary phenotype of fibroblasts in the 
dermal layer and improved epidermal differentiation (Lämmermann 
et al., 2018). 
Keratinocyte senescence had similar effects in 3D organotypic cul-
tures: Increasing the expression of p16INK4a in keratinocytes from 
young donors yielded a thinner epidermal layer like that from older 
donors, while decreasing p16INK4A in keratinocytes from older donors 
resulted in improved epidermal thickness (Adamus et al., 2014). Simi-
larly, specific ablation of senescent cells in human epidermal equivalents 
containing UV-induced senescent melanocytes by treatment with the 
senolytic drug ABT-737 reduced frequencies of senescent melanocytes 
and increased the thickness of the epidermal equivalents. Similar results 
were obtained by treatment with the mitochondria-targeted antioxidant 
MitoQ, in agreement with a causal role for oxidative stress in 
UV-induced senescence of melanocytes (Victorelli et al., 2019). 
3.3. In vivo senolytic and senostatic interventions: effects on skin ageing 
Until now, there are few studies that report the impact of a modifi-
cation of senescent cell frequencies on skin ageing in vivo. A summary of 
these is given in Table 3. 
3.3.1. Murine models 
A few studies have experimentally modified numbers of senescent 
cells in mouse skin. Deletion of the antioxidant gene SOD2 in mice 
Table 3 
Effects of senolytic and senostatic interventions on skin ageing.  
Anti-senescence intervention Effects on skin ageing Species 
ABT-737 (senolytic) Increased hair follicle stem cell proliferation, reduced senescent melanocytes, rescued epidermal atrophy (Yosef et al., 2016) 
Reduction of compensatory hyperplasia and papilloma inducing WNT activity in mice overexpressing p16INK4a in basal keratinocytes 
(Azazmeh et al., 2020) 
Mouse 
Mouse 
D+Q (senolytic) Reduction of p16INK4a and p21WAF1/CIP1-positive epidermal cell frequencies (Hickson et al., 2019) Human 
Fisetin (senolytic) Topical application to UV-irradiated skin improved TEWL and inflammation markers (Wu et al., 2017) Mouse 
Thermocoagulation in upper 
dermis 
Reduced skin pigmentation and increased lightness in senile lentigo (Yoon et al., 2018) Human 
Dermabrasion Improved collagen synthesis and UV response in sun-protected aged skin (Lewis et al., 2011) Human 
Rapamycin Topical application reduced wrinkles and sagging of skin, increased dermal volume, increased expression of collagen VII (Chung et al., 
2019) 
Human 
Metformin Reduced UVB-induced epidermal hyperplasia and carcinogenesis (Wu et al., 2013) Mouse  
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resulted in increased oxidative stress, mitochondrial dysfunction and 
induction of DNA damage in skin. Concomitantly, increased SA-β-Gal 
activity in the epidermis and higher p16INK4a levels in skin were 
observed, together with increased transglutaminase1 and decreased 
keratin K10 and K1 mRNA levels and decreased epidermal thickness, 
indicating enhanced terminal differentiation in the epidermis of mice 
with high oxidative stress and increased senescent cell frequencies 
(Velarde et al., 2012). The increase of senescent, p16INK4A-positive 
cells might be responsible for changes in connective tissue abundance 
and composition in this model (Treiber et al., 2011). Induction of 
senescence in basal keratinocytes by induced expression of p14ARF 
under control of the keratin K5 promoter resulted in persistently 
enhanced numbers of basal keratinocytes displaying Sen-β-Gal positivity 
and other markers of senescence. This resulted in hair follicle stem cell 
dysfunction evident by a dramatic decrease in the numbers of developed 
hair follicles, and progressive and persistent hair loss (alopecia). Effects 
on epidermal thickness were inconsistent, because of a transient in-
duction of hyperproliferation from p14ARF-nonexpressing stem cells 
(Tokarsky-Amiel et al., 2013). Similarly, increased numbers of senescent 
basal keratinocytes, stem cell dysfunction and alopecia were seen 
following overexpression of a K5-p16INK4a transgene (Azazmeh et al., 
2020). However, long-term activation of the transgene (for 6 months) 
did not resemble a premature ageing phenotype in the epidermis. 
Rather, it resulted in epidermal hyperplasia and dysplasia with hyper-
proliferation of (mostly) p16INK4a-nonexpressing basal cells, but 
delayed regeneration after wounding. Hyperplasia and formation of 
epidermal papilloma after carcinogen treatment was induced via WNT 
signaling from p16INK4a-expressing, partially senescent cells. 
The Bcl-2 protein-family inhibitor ABT-737 is a first-generation 
senolytic, and treatment of K5-p16INK4a transgenic mice after 6 
months of induction of the transgene reduced p16INK4a-positive cells, 
reversed hyperplasia and diminished activation of the WNT pathway 
(Azazmeh et al., 2020). Similarly, treatment of K5-p14ARF mice 
(Tokarsky-Amiel et al., 2013) with ABT-737 efficiently eliminated se-
nescent cells from the epidermis leading to an increase in hair-follicle 
stem cell proliferation (Yosef et al., 2016). 
Fisetin is a senolytic with a specificity for endothelial cells (but not 
for fibroblasts or adipocytes) (Zhu et al., 2017) that has been shown to 
increase health span in mice (Yousefzadeh et al., 2018). When applied 
daily for 10 weeks to skin of UV-irradiated hairless mice it improved 
TEWL and reduced inflammation (Xiao et al., 2021). 
Caloric restriction (da Silva et al., 2019; Ogrodnik et al., 2017) and 
caloric restriction mimetics like rapamycin (Blagosklonny, 2018) or 
metformin (Moiseeva et al., 2013) inhibit the senescent phenotype, 
specifically the SASP, at least partially by suppressing signaling through 
mTORC1 and mTORC2, which is persistently activated in senescence 
(Carroll et al., 2017). The senostatic activity of these interventions 
suppresses the spreading of the senescent phenotype from one cell to the 
other, helping to reduce senescent cell numbers in immunocompetent 
hosts (da Silva et al., 2019) and making the mTOR pathway a target for 
senescent cell elimination. Rapamycin efficiently slowed down ageing in 
mice (Harrison et al., 2009; Wilkinson et al., 2012) but effects on skin 
ageing were not reported in these studies. There is little evidence for an 
age-delaying effect of caloric restriction specifically in skin (Choi, 2020). 
Topical application of rapamycin did not improve cutaneous wound 
healing, although metformin had a strong positive effect (Zhao et al., 
2017). Metformin reduced the SASP of UV-irradiated keratinocytes in 
vitro and alleviated UVB-induced skin damage in mice after topical 
administration (Xiao et al., 2021). 
3.3.2. Clinical studies 
A study with 9 patients with diabetic kidney disease recently showed 
that a short systemic intervention with the senolytic combination of 
Dasatinib and Quercetin can reduce frequencies of senescent cells 
(assessed as p16INK4a- and p21WAF1/CIP1-positive cells) not only in 
adipose tissue but also in the epidermis, together with a reduction in 
circulating SASP factors. However, effects on skin function or quality 
were not reported (Hickson et al., 2019). 
Interventions aimed at improving aged skin function in humans so 
far relied on more indirect measures to reduce skin cell senescence. 
Dermabrasion is known to promote collagen remodeling and re- 
epithelialisation (Smith, 2014). In a small study with geriatric volun-
teers, it reduced frequencies of senescent fibroblasts in the upper dermis, 
increased papillary thickness, upregulated IGF1 expression and 
improved the UVB response in sun-protected aged skin (Lewis et al., 
2011). Senescent fibroblasts in the upper dermis were shown to enhance 
melanin production and drive skin hyperpigmentation in vitro and ex 
vivo. Accordingly, 10 volunteers with senile lentigo were treated with 
microneedle radiofrequency for 6 weeks, which reduced both fre-
quencies of p16INK4a-positive cells in the upper dermis and epidermal 
pigmentation in the treated area (Yoon et al., 2018). 
Metformin has frequently been used for treatment of cutaneous 
disorders including skin tumors, psoriasis, hyperpigmentation (Bubna, 
2016). Whether any of the beneficial effects are related to its senostatic 
properties, has not been assessed. Topical rapamycin has been applied in 
multiple clinical studies, mostly for treatment of patients with angiofi-
bromas linked to tuberous sclerosis complex (Leducq et al., 2019). More 
recently, a small randomized prospective clinical trial was performed to 
test whether topical application of rapamycin in low concentration 
could reduce senescence markers and improve function and appearance 
of photoaged skin (ClinicalTrials.gov Identifier: NCT03103893). Topical 
rapamycin reduced the expression of p16INK4a consistent with a 
reduction in cellular senescence. This change was accompanied by an 
improvement in clinical appearance of the skin and histological markers 
of aging and by an increase in collagen VII, which is critical to the 
integrity of the basement membrane (Chung et al., 2019). 
Finally, it is interesting to note that the hereditary premature ageing 
disorders Werner syndrome, Xeroderma pigmentosum and Hutchinson- 
Gilford progeria are all due to defects in DNA repair or nuclear organi-
zation and thus associated with accelerated cellular senescence and 
greatly enhanced age-related phenotypes in the skin (Davis et al., 2007; 
Demaria et al., 2015; Liu et al., 2006). 
In conclusion, there is a good amount of pre-clinical and clinical data 
showing a strong positive correlation between reduction of senescent 
cells frequencies and functional improvement of skin. 
4. Conclusions and open questions 
Research in recent years has convincingly proven that cell senes-
cence is a pathophysiologically relevant cause of age-associated multi-
morbidity and functional losses. Organism-wide ablation of senescent 
cells has resulted in prolonged lifespan and better maintenance of 
function in multiple organs and tissues (Robbins et al., 2021), while 
senescent cell transplantation caused shortened lifespan and 
ageing-associated dysfunction in remote organs (Xu et al., 2018a). Via a 
generalized SASP, senescence spreads from cell to cell in vitro (Nelson 
et al., 2012) and in vivo (Acosta et al., 2013; da Silva et al., 2019; Xu 
et al., 2018a). As tools to ablate senescent cells specifically in one cell 
type or organ are only now emerging, discrimination between systemic 
and cell-autonomous effects of senescence has only seldom been ach-
ieved; the identification of a cell-autonomous induction of steatosis in 
senescent hepatocytes being an exception (Ogrodnik et al., 2017). 
Whether senescence of skin cells makes a significant causal contri-
bution to skin ageing can still not be conclusively decided. Senescent 
cells accumulate with age in all major compartments of the skin, and the 
inclusion of increased numbers of senescent cells recapitulates at least 
some ageing-associated changes in human 3D skin models (see chapters 
3.1 and 3.2 above). However, animal intervention experiments and 
clinical intervention trials have been less conclusive about the role of 
senescence in skin ageing as compared to other organs (see chapter 3.3) 
for several different reasons: 
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i) Studies with transgenic induction of senescence in keratinocytes 
(Azazmeh et al., 2020; Tokarsky-Amiel et al., 2013) recapitulated 
some features of intrinsic skin ageing (e.g., loss of regenerative 
capacity), but also revealed phenotypes not normally seen during 
ageing (for instance, compensatory hyperproliferation). This 
might however not be surprising as skin is a highly regenerative 
organ, requiring an exact long-term balance of proliferative and 
differentiation activities of stem and progenitor cells. Senescent 
cells can significantly impact this balance via a multitude of 
factors secreted as part of the SASP. Importantly, SASP factors can 
either stimulate (Antelo-Iglesias et al., 2021) or inhibit (Ogrodnik 
et al., 2019) regeneration. For instance, transient senescence was 
found to be a requirement for successful skin wound healing 
(Demaria et al., 2014; Jun and Lau, 2010), while correlative data 
indicate a role for persistent, pre-existing senescence for chro-
nicity of wounds in old and/or diabetic individuals (Stanley and 
Osler, 2001). Given how little is known how different factors 
including cell type, senescence inducer or progression of the 
phenotype determine SASP composition (Kirschner et al., 2020), 
it will be very complicated to predict how senescent cells will 
change proliferation and differentiation in the epidermis.  
ii) Successful intervention studies have often been performed with 
rather unspecific interventions. Caloric restriction or metformin, 
for example, have anti-senescence activities, but in addition act 
via a plethora of molecular pathways, some of which may be 
related to senescence but others not (Hu et al., 2021). Similarly, 
increasing oxidative stress in skin e.g., (Velarde et al., 2012) 
might or might not primarily impact via senescent cell 
generation.  
iii) While the reduction of senescence markers in skin after systemic 
treatment with the senolytic combination Dasatinib + Quercetin 
has been demonstrated in one clinical study (Hickson et al., 
2019), clinical studies showing improvement of skin function 
after senolytic intervention are still missing. Similarly, we did 
find only a single preclinical study showing relief of UV damage 
in mouse skin following topical senolytic (fisetin) application 
(Wu et al., 2017).  
iv) These limitations in the present knowledge clearly indicate some 
factors that require more experimental consideration by the 
research community. Evidently, it will be necessary to see 
whether, and to which extent, specific ablation of senescent cells 
(and ideally, of specific cell types in the skin) can slow down skin 
ageing in vivo. Importantly, it needs to be tested whether ablation 
of senescent cells in aged skin before wounding can improve the 
healing of wounds that otherwise would become chronic. It is 
necessary to understand more about the differences between 
persistent and transient senescent cells in skin. Are they experi-
encing intrinsically different senescence phenotypes, or is a dif-
ference in senescence kinetics more important? Also, very little is 
known about how the composition of the extracellular matrix in 
the dermal layer, which changes significantly with age (McCabe 
et al., 2020), changes properties of senescent cells. It is interesting 
to note that the inclusion of fibroblasts that were rendered se-
nescent in 2D culture into a collagen matrix resulted in reduced 
proliferation and differentiation within the epidermal layer in 3D 
full thickness skin equivalents (Weinmüllner et al., 2020), while 
the same senescent fibroblasts when embedded in a polystyrene 
scaffold caused a thickening of the epidermal layer (unpub-
lished). Whether these differences might be informative with 
respect to the different mechanisms determining intrinsic vs 
UV-induced skin ageing, remains to be seen. Finally, there is 
insufficient understanding of how different cell types interact in 
the skin during progression to senescence. Are melanocytes the 
primary cell type that becomes most easily senescent in skin as 
suggested (Victorelli et al., 2019; Waaijer et al., 2016), or are they 
just more sensitive to secondary signals from senescent kerati-
nocytes or fibroblasts? 
Taken together, we feel that the evidence that cellular senescence is a 
relevant cause of skin ageing is highly suggestive but needs improve-
ment to become conclusive. However, there is strong evidence existing 
today to assume that better understanding of cell senescence in skin may 
lead to a breakthrough in interventions into skin ageing. 
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